FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3088842413> ?p ?o ?g. }

• W3088842413 endingPage "2000918" @default.
• W3088842413 startingPage "2000918" @default.
• W3088842413 abstract "Accelerated lung function decline has been associated with increased risk of cardiovascular disease (CVD) in a general population, but little is known about this association in chronic obstructive pulmonary disease (COPD). We investigated the association between accelerated lung function decline and CVD outcomes and mortality in a primary care COPD population.COPD patients without a history of CVD were identified in the Clinical Practice Research Datalink (CPRD)-GOLD primary care dataset (n=36 382). Accelerated decline in forced expiratory volume in 1 s (FEV1) was defined using the fastest quartile of the COPD population's decline. A Cox regression was used to assess the association between baseline accelerated FEV1 decline and a composite CVD outcome over follow-up (myocardial infarction, ischaemic stroke, heart failure, atrial fibrillation, coronary artery disease and CVD mortality). The model was adjusted for age, sex, smoking status, body mass index, history of asthma, hypertension, diabetes, statin use, Modified Medical Research Council (mMRC) dyspnoea score, exacerbation frequency and baseline FEV1 % predicted.6110 COPD patients (16.8%) had a CVD event during follow-up; median length of follow-up was 3.6 years (interquartile range (IQR) 1.7-6.1 years). Median rate of FEV1 decline was -19.4 mL·year-1 (IQR -40.5-1.9); 9095 patients (25%) had accelerated FEV1 decline (> -40.5 mL·year-1), 27 287 (75%) did not (≤ -40.5 mL·year-1). Risk of CVD and mortality was similar between patients with and without accelerated FEV1 decline (HRadj 0.98, 95% CI 0.90-1.06). Corresponding risk estimates were 0.99 (95% CI 0.83-1.20) for heart failure, 0.89 (95% CI 0.70-1.12) for myocardial infarction, 1.01 (95% CI 0.82-1.23) for stroke, 0.97 (95% CI 0.81-1.15) for atrial fibrillation, 1.02 (95% CI 0.87-1.19) for coronary artery disease and 0.94 (95% CI 0.71-1.25) for CVD mortality. Rather, risk of CVD was associated with a mMRC score ≤2 and two or more exacerbations in the year prior.CVD outcomes and mortality were associated with exacerbation frequency and severity and increased mMRC dyspnoea score but not with accelerated FEV1 decline." @default.
• W3088842413 created "2020-10-01" @default.
• W3088842413 creator A5036977965 @default.
• W3088842413 creator A5044010239 @default.
• W3088842413 creator A5045847771 @default.
• W3088842413 creator A5046531226 @default.
• W3088842413 creator A5054646996 @default.
• W3088842413 creator A5076213012 @default.
• W3088842413 date "2020-09-24" @default.
• W3088842413 modified "2023-10-15" @default.
• W3088842413 title "Accelerated FEV₁decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients" @default.
• W3088842413 cites W181081029 @default.
• W3088842413 cites W1992286318 @default.
• W3088842413 cites W2001613934 @default.
• W3088842413 cites W2008212067 @default.
• W3088842413 cites W2027734522 @default.
• W3088842413 cites W2076467927 @default.
• W3088842413 cites W2094354458 @default.
• W3088842413 cites W2117837864 @default.
• W3088842413 cites W2119852447 @default.
• W3088842413 cites W2132683688 @default.
• W3088842413 cites W2138246183 @default.
• W3088842413 cites W2138808616 @default.
• W3088842413 cites W2152282591 @default.
• W3088842413 cites W2171676943 @default.
• W3088842413 cites W2172005465 @default.
• W3088842413 cites W2265924223 @default.
• W3088842413 cites W2295597785 @default.
• W3088842413 cites W2398454823 @default.
• W3088842413 cites W2407358117 @default.
• W3088842413 cites W2510919056 @default.
• W3088842413 cites W2609815990 @default.
• W3088842413 cites W2622715917 @default.
• W3088842413 cites W2738562386 @default.
• W3088842413 cites W2789802763 @default.
• W3088842413 cites W2794221242 @default.
• W3088842413 cites W2794418690 @default.
• W3088842413 cites W2800476967 @default.
• W3088842413 cites W2803032401 @default.
• W3088842413 cites W2888816123 @default.
• W3088842413 cites W2895246789 @default.
• W3088842413 cites W2899694365 @default.
• W3088842413 cites W2904124576 @default.
• W3088842413 cites W2955318738 @default.
• W3088842413 cites W2962551685 @default.
• W3088842413 cites W3026537932 @default.
• W3088842413 doi "https://doi.org/10.1183/13993003.00918-2020" @default.
• W3088842413 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7930472" @default.
• W3088842413 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32972984" @default.
• W3088842413 hasPublicationYear "2020" @default.
• W3088842413 type Work @default.
• W3088842413 sameAs 3088842413 @default.
• W3088842413 citedByCount "24" @default.
• W3088842413 countsByYear W30888424132021 @default.
• W3088842413 countsByYear W30888424132022 @default.
• W3088842413 countsByYear W30888424132023 @default.
• W3088842413 crossrefType "journal-article" @default.
• W3088842413 hasAuthorship W3088842413A5036977965 @default.
• W3088842413 hasAuthorship W3088842413A5044010239 @default.
• W3088842413 hasAuthorship W3088842413A5045847771 @default.
• W3088842413 hasAuthorship W3088842413A5046531226 @default.
• W3088842413 hasAuthorship W3088842413A5054646996 @default.
• W3088842413 hasAuthorship W3088842413A5076213012 @default.
• W3088842413 hasBestOaLocation W30888424131 @default.
• W3088842413 hasConcept C119060515 @default.
• W3088842413 hasConcept C126322002 @default.
• W3088842413 hasConcept C127413603 @default.
• W3088842413 hasConcept C164705383 @default.
• W3088842413 hasConcept C2776780178 @default.
• W3088842413 hasConcept C2777014857 @default.
• W3088842413 hasConcept C2779161974 @default.
• W3088842413 hasConcept C2780645631 @default.
• W3088842413 hasConcept C2908647359 @default.
• W3088842413 hasConcept C44249647 @default.
• W3088842413 hasConcept C500558357 @default.
• W3088842413 hasConcept C68443243 @default.
• W3088842413 hasConcept C71924100 @default.
• W3088842413 hasConcept C78519656 @default.
• W3088842413 hasConcept C99454951 @default.
• W3088842413 hasConceptScore W3088842413C119060515 @default.
• W3088842413 hasConceptScore W3088842413C126322002 @default.
• W3088842413 hasConceptScore W3088842413C127413603 @default.
• W3088842413 hasConceptScore W3088842413C164705383 @default.
• W3088842413 hasConceptScore W3088842413C2776780178 @default.
• W3088842413 hasConceptScore W3088842413C2777014857 @default.
• W3088842413 hasConceptScore W3088842413C2779161974 @default.
• W3088842413 hasConceptScore W3088842413C2780645631 @default.
• W3088842413 hasConceptScore W3088842413C2908647359 @default.
• W3088842413 hasConceptScore W3088842413C44249647 @default.
• W3088842413 hasConceptScore W3088842413C500558357 @default.
• W3088842413 hasConceptScore W3088842413C68443243 @default.
• W3088842413 hasConceptScore W3088842413C71924100 @default.
• W3088842413 hasConceptScore W3088842413C78519656 @default.
• W3088842413 hasConceptScore W3088842413C99454951 @default.
• W3088842413 hasFunder F4320320055 @default.
• W3088842413 hasIssue "3" @default.
• W3088842413 hasLocation W30888424131 @default.
• W3088842413 hasLocation W30888424132 @default.

• next